Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FEGXY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $93,202
Award facts
- Contract value 100% obligated
- $93,202.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Gemtesa 75 mg tablets in quantities of 90 units. This competitively awarded contract, valued at $93,202.03, is structured as a firm fixed-price delivery order with a completion date of August 29, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime contract vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, has demonstrated substantial capability in federal medical procurement through its extensive portfolio of contract awards with the Defense Logistics Agency. The company serves as a critical vendor for military and veteran healthcare systems, supplying a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This award reflects AmerisourceBergen's competitive standing in federal procurement and its role as a key pharmaceutical supplier within the Defense Health Agency's medical supply chain. No set-aside designation was applied to this contract.
Quick answers
Who was awarded contract SPE2DB25FEGXY?
SPE2DB25FEGXY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FEGXY worth?
The government has obligated $93,202 on SPE2DB25FEGXY.
Is contract SPE2DB25FEGXY an order under another contract?
Yes. SPE2DB25FEGXY is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEGXY competed?
The extent of competition for SPE2DB25FEGXY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award